mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.9 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
0.0085 |
0.9 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |